Regeneron scientists discover key to excess bone growth in rare disease
 

Regeneron scientists discover key to excess bone growth in rare disease
CHICAGO (Reuters) - Scientists at U.S. biotech**logy company Regeneron Pharmaceuticals researching a rare genetic disease that traps sufferers in a second skeleton have discovered a treatment that shuts down excessive bone growth in mice engineered to develop the illness.


http://rc.feedsportal.com/r/23838509...32/rc/1/rc.img

http://rc.feedsportal.com/r/23838509...32/rc/2/rc.img

http://rc.feedsportal.com/r/23838509...32/rc/3/rc.img

http://da.feedsportal.com/r/23838509...7/sc/32/a2.img
http://adchoice.feedsportal.com/r/23.../sc/32/ach.imghttp://pi.feedsportal.com/r/23838509.../sc/32/a2t.imghttp://pi2.feedsportal.com/r/2383850...sc/32/a2t2.imghttp://i0.wp.com/reuters.us.feedspor...f?resize=1%2C1 http://feeds.feedburner.com/~ff/reut...?d=yIl2AUoC8zA http://feeds.feedburner.com/~ff/reut...p0:F7zBnMyn0Lo http://feeds.feedburner.com/~ff/reut...p0:V_sGLiPBpWU
http://feeds.feedburner.com/~r/reute...~4/j-rOqdJJqm0